FLNA
Filana Therapeutics, Inc. NASDAQ Listed Jul 14, 2000$0.97
-2.74%
vs $1.00
Mkt Cap $46.9M
52w Low $0.86
2.7% of range
52w High $4.98
50d MA $1.16
200d MA $1.94
P/E (TTM)
—
EV/EBITDA
—
P/B
0.6x
Debt/Equity
0.0x
ROE
-122.3%
P/FCF
-1.5x
RSI (14)
48.50
ATR (14)
$0.06
Beta
-0.68
50d MA
$1.16
200d MA
$1.94
Avg Volume
364.7K
Filana Therapeutics, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.
6801 N. Capital of Texas Highway · Austin, TX 78731 · US
Data updated apr 25, 2026 9:21am
· Source: financialmodelingprep.com